Učitavanje...
Assessment of Minimal Residual Disease in Myeloma and the Need for a Consensus Approach
Treatment options for myeloma continue to develop at a rapid pace, and it is becoming increasingly challenging to determine the optimal therapeutic approaches because demonstrating a clear survival benefit now requires many years of follow-up. The detection of minimal residual disease (MRD) is recog...
Spremljeno u:
| Izdano u: | Cytometry B Clin Cytom |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7511969/ https://ncbi.nlm.nih.gov/pubmed/26202864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cyto.b.21272 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|